| Product Type | Impurity Standards |
| CAT. No. | MRL-S06003 |
| CAS. No. | NA |
| Mol. Formula | C17H17FN2O4 |
| Mol. Weight | 332.33 |
| Synonyms | NA |
| Chemical Name | N-(4-((3-Fluorobenzyl)oxy)benzyl)-N-nitroso-L-alanine |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Safinamide. Nitrosamines are part of a broader class of compound Safinamide, a monoamine oxidase B (MAO-B) inhibitor, is utilized as an adjunct to levodopa/carbidopa therapy for Parkinsons disease. By selectively inhibiting MAO-B, the enzyme responsible for dopamine breakdown in the brain, safinamide increases dopamine levels, improving motor function and alleviating symptoms of Parkinsons Additionally, its unique non-dopaminergic effects, such as sodium channel blockade, contribute to its antiparkinsonian properties. Generally well-tolerated, safinamide represents a valuable treatment option, though careful monitoring for potential interactions is essential for optimal therapeutic outcomes in individuals with Parkinsons disease. Buy high quality N-Nitroso Safinamide Acid from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Safinamide Acid